Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2α in end-stage liver disease
Article first published online: 7 MAR 2007
Copyright © 2003 American Association for the Study of Liver Diseases
Volume 38, Issue 4, pages 1063–1064, October 2003
How to Cite
Tsikas, D., Rode, I., Becker, T., Nashan, B., Klempnauer, J. and Frölich, J. C. (2003), Elevated plasma and urine levels of ADMA and 15(S)-8-iso-PGF2α in end-stage liver disease. Hepatology, 38: 1063–1064. doi: 10.1002/hep.1840380440
- Issue published online: 7 MAR 2007
- Article first published online: 7 MAR 2007
- 4J Chromatogr B (in press)., , , , Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by GC-tandem MS as methyl ester tri(N-pentafluoropropionyl) derivative.
- 5Divergence in urinary 8-iso-PGF2α (iPF2α-III, 15-F2t-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF2α: possible methodological, mechanistic and clinical implications. J Chromatogr B 2003; 794: 237–255., , , , , , , et al.